Prevention of HIV in "Île-de-France"
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 24 Jul 2019
Price : $35 *
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms ANRS-PREVENIR
- 02 Jul 2019 Planned primary completion date changed from 1 Apr 2020 to 3 Apr 2020.
- 02 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 12 May 2017 Status changed from not yet recruiting to recruiting.